Yüklüyor......
Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
Long‐term exposure to lipid‐lowering drugs might affect Parkinson's disease (PD) risk. We conducted Mendelian randomization analyses where genetic variants indexed expected effects of modulating lipid‐lowering drug targets on PD. Statin exposure was not predicted to increase PD risk, although r...
Kaydedildi:
| Yayımlandı: | Ann Neurol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693098/ https://ncbi.nlm.nih.gov/pubmed/32841444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25880 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|